C83.68 Undifferentiated (diffuse) non-Hodgkin's lymphoma, lymph nodes of multiple sites

Name of the Condition

• Undifferentiated (diffuse) non-Hodgkin's lymphoma, lymph nodes of multiple sites
• Also known as ICD-10 code C83.68

Summary

Undifferentiated (diffuse) non-Hodgkin's lymphoma is a subtype of non-Hodgkin lymphoma characterized by the malignant proliferation of lymphoid cells that lack distinct differentiation or follicular structure. It typically involves abnormal growth of B-cells or T-cells in lymph nodes or other lymphoid tissues, with a diffuse pattern of spread. This condition specifically affects lymph nodes of multiple sites and is part of the broader category of non-follicular lymphomas.

Causes

The exact cause of undifferentiated (diffuse) non-Hodgkin's lymphoma remains unknown. It is thought to involve genetic mutations or abnormalities in lymphoid cell development, though specific triggers are not well-defined. Research suggests potential links to immune system dysregulation or prior infections, but no definitive etiology has been established.

Risk Factors

• Age: More common in older adults.
• Family history of lymphoma.
• Prior exposure to radiation or certain chemicals.
• Chronic infections, such as hepatitis C or HIV.
• Immunosuppressive conditions or treatments.

Symptoms

• Swollen, painless lymph nodes in multiple areas.
• Unexplained weight loss.
• Fever.
• Night sweats.
• Fatigue.
• Loss of appetite.

Diagnosis

Diagnosis typically involves a combination of physical examination, imaging studies (e.g., CT or PET scans), and biopsy of affected lymph nodes. Pathological analysis confirms the presence of undifferentiated (diffuse) non-Hodgkin's lymphoma, with additional tests (e.g., flow cytometry, immunohistochemistry) used to determine cell type and subtype. Staging helps assess the extent of disease spread.

Treatment Options

Treatment depends on the stage, subtype, and patient factors. Options may include chemotherapy, immunotherapy, targeted therapy, or radiation therapy. Stem cell transplantation may be considered for advanced or refractory cases. Multidisciplinary care involving oncologists, hematologists, and other specialists is often recommended.

Prognosis and Follow-Up

Prognosis varies based on subtype, stage, and response to treatment. Regular follow-up with imaging and clinical assessments is essential to monitor for recurrence or progression. Long-term surveillance may be required, as some subtypes have a higher risk of relapse.

Complications

Potential complications include infection due to immunosuppression, organ dysfunction from tumor burden, treatment-related side effects (e.g., cytopenias, organ toxicity), and transformation to a more aggressive lymphoma subtype.

Lifestyle & Prevention

While prevention is not fully established, maintaining a healthy immune system through balanced nutrition, regular exercise, and avoiding known risk factors (e.g., excessive radiation exposure) may support overall health. Prompt treatment of chronic infections is advisable.

When to Seek Professional Help

Seek medical attention for persistent swollen lymph nodes, unexplained weight loss, fever, night sweats, or fatigue. Early evaluation is critical for timely diagnosis and management.

Tips for Medical Coders

Use C83.68 for undifferentiated (diffuse) non-Hodgkin's lymphoma involving lymph nodes of multiple sites. Ensure documentation specifies the diffuse pattern and multiple-site involvement to support code assignment. Verify that other site-specific codes (e.g., head/neck, intrathoracic) are not applicable before using this code.